SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PLYA, SLRN, NVRO, AMPS on Behalf of ShareholdersNEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Nevro Corp. (
NYSENVRO) to Globus Medical, Inc.
NYSE: GMEDNYSEGMED)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVRO, SLRN, TGI, PTMN on Behalf of ShareholdersNEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
NVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Nevro Corp. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Nevro Corp. (
NYSENVRO) to Globus Medical for $5.85 per share is fair to Nevro shareholders.
Shareholder Alert: Ademi & Fruchter LLP Investigates Whether Nevro Corp. Is Obtaining a Fair Price for Its Public Shareholders
Ademi & Fruchter LLP is investigating Nevro (
NYSENVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical.
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for PatientsAUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (
NYSEGMED), a leading musculoskeletal solutions company, and Nevro Corp.
NYSE: NVRONYSENVRO)
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-OffAs the opioid crisis continues to grip communities worldwide, a ray of optimism emerges in the form of innovative, non-opioid therapies and drug development. Publicly traded companies like Nevro Corp. (
NYSENVRO), a leader in spinal cord stimulation devices, and Medtronic
NYSE: MDTNYSEMDT)
